Dokter Terapi radiasi untuk kanker kolorektal terbaik di luar negeri — Halaman 2

Dr. Mohamed Mahmoud Abdelhakim adalah Profesor Onkologi Radiasi di Institut Kanker Nasional Universitas Kairo. Beliau menjabat sebagai Kepala Onkologi Radiasi di Rumah Sakit Shefa al Orman. Dr. Abdelhakim menangani kanker kompleks, termasuk kanker payudara, sarkoma jaringan lunak, dan tumor ginekologi. Beliau adalah anggota ESTRO dan ESMO.

• Melakukan brakiterapi dengan panduan gambar dan radioterapi stereotaktik.
• Menggunakan IMRT, VMAT, SRS, dan SBRT untuk penargetan tumor yang presisi.
• Menyediakan iradiasi seluruh tubuh dan seluruh kulit untuk transplantasi sumsum tulang.
• Berpraktik di Rumah Sakit Shefa al Orman di Luxor yang terakreditasi ESMO.

Dr. Yaacov Lawrence adalah Kepala Onkologi Radiasi di Sheba Medical Center. Beliau memiliki spesialisasi dalam terapi radiasi presisi dan neuro-onkologi. Dr. Lawrence adalah pelopor bedah radio pleksus celiac untuk manajemen nyeri kanker pankreas. Beliau memegang gelar FASTRO, salah satu penghargaan tertinggi di bidang spesialisasi beliau.

• Memimpin Program Kanker Gastrointestinal di Sheba Medical Center.
• Melakukan bedah radio stereotaktik untuk tumor otak dan kanker sistem saraf.
• Penulis lebih dari 280 publikasi ilmiah tentang protokol radiasi yang dipersonalisasi.
• Menyelesaikan pelatihan fellowship onkologi radiasi di Thomas Jefferson University.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Ahn Jin Seok berspesialisasi dalam terapi radiasi untuk kanker kolorektal di Samsung Medical Center.

• Onkolog dengan pengalaman luas dalam menangani kanker kolorektal
• Berpraktik di Samsung Medical Center – fasilitas perawatan kanker terkemuka

Onkolog yang berspesialisasi dalam terapi radiasi di Samsung Medical Center.

• Berpengalaman dalam mengobati kanker kolorektal dengan radiasi
• Bekerja di pusat medis terkemuka di Korea Selatan
• Berfokus pada rencana perawatan yang dipersonalisasi untuk pasien

Profesor Lim Do Hoon memimpin Departemen Onkologi Radiasi di Samsung Medical Center, dengan spesialisasi pada kanker gastrointestinal dan kanker langka.

• Terlatih di Rumah Sakit Universitas Nasional Seoul dan Samsung Medical Center
• Spesialis tumor lambung, pankreatobilier, dan pediatrik
• Pakar terapi radiasi untuk kasus gastrointestinal yang kompleks
• Anggota Asosiasi Kanker Korea dan Masyarakat Onkologi Radiasi Korea

Dr. Choi Du Kho berspesialisasi dalam bedah jantung dengan pengalaman lebih dari di Samsung Medical Center.

• Pakar bedah jantung berbantuan robot
• Ahli dalam perbaikan dan penggantian katup
• Melakukan bedah jantung pediatrik

Prof. Miriam Ben-Harush adalah spesialis yang diakui secara internasional dalam onkologi anak dan transplantasi sumsum tulang di Rumah Sakit Anak Ruth Rappaport.

• Direktur Divisi Pediatri di Rambam Medical Center
• Penerima penghargaan Chevalier de la Legion d’Honneur
• Dinobatkan sebagai salah satu dokter paling peduli di dunia oleh Asosiasi Medis Dunia
• Anggota kelompok onkologi anak di AS

Dr. Raphael Pfeffer berspesialisasi dalam terapi radiasi untuk kanker kolorektal di Assuta Medical Center.

• Onkolog dan radiolog dengan keahlian ganda
• Berfokus pada perencanaan pengobatan radiasi yang tepat
• Bekerja di salah satu pusat medis terkemuka di Israel

Dr. Svetlana Zalmanova adalah spesialis radioterapi di Assuta Medical Center, yang berfokus pada pengobatan kanker kolorektal.

• Keahlian dalam pemberian terapi radiasi yang presisi
• Bekerja di pusat medis terkemuka di Israel
• Berdedikasi pada rencana perawatan yang dipersonalisasi

Prof. Tamer Atasever membawa 34 tahun keahlian kedokteran nuklir, termasuk peran kepemimpinan di institusi-institusi terkemuka Turki.

• Profesor di Rumah Sakit Universitas Medipol dan Universitas Gazi
• Mantan Direktur Kedokteran Nuklir di Laboratorium Ankara Order
• Anggota Asosiasi Kedokteran Nuklir Eropa
• Berspesialisasi dalam kedokteran nuklir diagnostik dan terapeutik tingkat lanjut

Dr. Sadir Alrawi adalah ahli bedah onkologi bersertifikat. Beliau berspesialisasi dalam kanker saluran cerna bagian atas, kepala dan leher, bedah minimal invasif, kanker payudara, dan kanker kolorektal. Beliau juga memiliki keahlian dalam kemoperfusi panas. Dr. Alrawi menjabat sebagai Direktur Layanan Onkologi di sistem Rumah Sakit VPS di UEA dan wilayah MENA. Beliau mengawasi beberapa pusat rujukan onkologi tersier.

Dr. Alrawi memegang sertifikasi dewan Amerika dan Inggris. Beliau menyelesaikan fellowship di Roswell Park Cancer Institute. Sebelumnya, beliau memimpin divisi onkologi di Rumah Sakit Al Zahra, Rumah Sakit Tawam (afiliasi Johns Hopkins), dan 21st Century Oncology di Florida. Dr. Alrawi telah banyak menerbitkan karya dan sering memberikan ceramah sebagai pembicara tamu. Beliau tetap aktif dalam penelitian dan pendidikan onkologi.

Dr. Raj telah melakukan lebih dari 50.000 operasi kanker selama _doctor_2241_tahun_, dengan spesialisasi Onkologi Bedah Payudara dan Toraks di HCG Manavata Cancer Centre.

• Terlatih di Tata Memorial Hospital dan Royal College of Surgeons, Edinburgh
• Terlibat dalam lebih dari 200 uji klinis, termasuk studi fase 1-3
• Profesor untuk DNB Superspecialty Surgical Oncology dan Bedah Payudara
• Berfokus pada peningkatan kualitas hidup di samping pengobatan

Dr. Shaunak berspesialisasi dalam terapi target untuk kanker kolorektal, dengan penelitian yang dipresentasikan di American Society of Clinical Oncology.

• Pelatihan Onkologi Medis di Rumah Sakit Indraprastha Apollo
• Keahlian dalam dasar molekuler kanker
• Penelitian yang dipresentasikan tentang kanker lambung di ASCO
• Residensi senior di Rumah Sakit Kanker Jawaharlal Nehru

Dr. Lalit Banswal telah melakukan lebih dari 10.000 operasi besar selama _doctor_2291_tahun_ pengalamannya, dengan fokus pada kanker gastrointestinal di HCG Manavata Cancer Centre.

• Memiliki fellowship dalam Onkologi Bedah di Tata Medical Centre, Kolkata
• Spesialis bedah kanker minimal invasif dengan hasil yang sangat baik
• Mantan Asisten Profesor di State Cancer Institute dan Government Cancer Hospital, Aurangabad
• Telah menerbitkan berbagai makalah penelitian nasional dan internasional
• Dikenal karena pendekatan yang etis dan ramah pasien

Dr. Ahmer Arif Shaikh berspesialisasi dalam bedah kanker mulut dengan fokus pada pelestarian organ dan rehabilitasi fungsional di HCG Manavata Cancer Centre.

• 15 tahun pengalaman dalam onkologi bedah
• Terlatih melalui fellowship dalam Onkologi Bedah Kepala & Leher
• Mahir dalam bedah maksilofasial serta bedah kepala & leher utama
• Peneliti dengan berbagai publikasi

Dr. Shruti Kate berspesialisasi dalam imunoterapi dan terapi metronomik untuk kanker stadium lanjut, dengan penelitian yang dipresentasikan pada Konferensi Dunia tentang Kanker Paru-paru.

• Terlatih di Tata Memorial Hospital – salah satu pusat kanker terkemuka di India
• Keahlian dalam kanker paru-paru, payudara, ginekologi, dan genitourinari
• Anggota ASCO, ESMO, dan organisasi onkologi terkemuka lainnya
• Penerima penghargaan perjalanan bergengsi untuk WCLC 2018